BlockBeats News, November 13, Ethereum treasury company SharpLink Gaming released its third-quarter 2025 financial report. The net profit surged to approximately $1.043 billion, with earnings per share of $0.62, compared to a net loss of $885,000 in the same period last year; total revenue was around $10.8 million, a year-on-year increase of over 1100%; total crypto assets amounted to around $3 billion, with $11.1 million in cash and $26.7 million in USDC stablecoin.
As of September 30, SharpLink held about 817,700 ETH, which increased to 861,250 ETH on November 9. In terms of operations, the Board of Directors approved a $1.5 billion stock repurchase plan, repurchasing 1.938 million shares at a cost of $31.6 million. Additionally, the company also announced that it will deploy $200 million worth of ETH on Linea, earning enhanced yield through ether.fi and EigenCloud.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.









Latest Crypto Market Snapshot as of August 22, 2025 BTC Soars to $115,250.00 ETH Hits $4,450.75 XRP Climbs…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.




